iShares U.S. Pharmaceuticals ETF

Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production…
Read More...

Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe's most valuable company.But…
Read More...

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.Shelby…
Read More...

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |…
Read More...